SEARCH
= Paid-up subscribersNaltrexone lowers hospital admissions in alcohol use disorder. Practitioner October 2021;265(1852):7-9
Naltrexone lowers hospital admissions in alcohol use disorder
27 Oct 2021
The risk of hospitalisation for an alcohol-related or other cause is lower when patients with alcohol use disorder are treated with naltrexone alone or in combination with disulfiram or acamprosate, a nationwide Swedish study has found. However, acamprosate monotherapy was associated with an increased risk of hospital admission for an alcohol-related cause.
This article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.